Thu 25 Jun 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| Cilest® - Ethinylestradiol, Norgestimate | The reason for the recall is that dissolution testing of norgestimate. |
||
| TYKERB® - Lapatinib | Comparative data have shown that Lapatinib based regimens are less effective than trastuzumab based regimens in certain settings. |
||
| Plavix® - Clopidogrel | Regarding Bleeding Risk with Plavix in Atrial Fibrillation Patients. |
||
| Curacne® - Isotretinoin | Pregnancy Prevention Program |
||
| ROACCUTANE®- Isotretinoin | Pregnancy Prevention Program |
||
| Tysabri® - Connect | Risk of progressive multifocal leukoencephalopathy PML |
||
| Protelos® - Strontium ranelate | Increased risk of myocardial infarction |
||
| Miacalcic® - Calcitonin | increased risk of malignancies with long term calcitonin use |
||
| Solpadeine® - Paracetamol, Caffeine, Codeine Phosphate | The use of codeine containing products for children after tonsillectomy and /or adenoidectomy surgery |
||
| Vastarel® - Trimetazidine | Outcome of the Benefit-Risk Re-evaluation of Trimetazidine |
Last update date: 21/04/2024 at 10:00 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.